Source link : https://www.newshealth.biz/health-news/do-glp-1s-lower-vte-risk-in-people-with-type-2-diabetes/
Glucagon-like peptide 1 (GLP-1) receptor agonists led to a significant reduction in the risk for venous thromboembolism (VTE) among individuals with type 2 diabetes compared with dipeptidyl peptidase 4 (DPP-4) inhibitors, a recent analysis indicated. Overall, GLP-1 agonist use was associated with a 20% reduction in VTE compared with DPP-4 inhibitor use in those with […]
Author : News Health
Publish date : 2024-12-11 09:32:39
Copyright for syndicated content belongs to the linked Source.